337 related articles for article (PubMed ID: 24504326)
1. Functional analysis of a de novo GRIN2A missense mutation associated with early-onset epileptic encephalopathy.
Yuan H; Hansen KB; Zhang J; Pierson TM; Markello TC; Fajardo KV; Holloman CM; Golas G; Adams DR; Boerkoel CF; Gahl WA; Traynelis SF
Nat Commun; 2014; 5():3251. PubMed ID: 24504326
[TBL] [Abstract][Full Text] [Related]
2. Functional Evaluation of a De Novo
Chen W; Tankovic A; Burger PB; Kusumoto H; Traynelis SF; Yuan H
Mol Pharmacol; 2017 Apr; 91(4):317-330. PubMed ID: 28126851
[TBL] [Abstract][Full Text] [Related]
3. A de novo loss-of-function GRIN2A mutation associated with childhood focal epilepsy and acquired epileptic aphasia.
Gao K; Tankovic A; Zhang Y; Kusumoto H; Zhang J; Chen W; XiangWei W; Shaulsky GH; Hu C; Traynelis SF; Yuan H; Jiang Y
PLoS One; 2017; 12(2):e0170818. PubMed ID: 28182669
[TBL] [Abstract][Full Text] [Related]
4. GRIN2D Recurrent De Novo Dominant Mutation Causes a Severe Epileptic Encephalopathy Treatable with NMDA Receptor Channel Blockers.
Li D; Yuan H; Ortiz-Gonzalez XR; Marsh ED; Tian L; McCormick EM; Kosobucki GJ; Chen W; Schulien AJ; Chiavacci R; Tankovic A; Naase C; Brueckner F; von Stülpnagel-Steinbeis C; Hu C; Kusumoto H; Hedrich UB; Elsen G; Hörtnagel K; Aizenman E; Lemke JR; Hakonarson H; Traynelis SF; Falk MJ
Am J Hum Genet; 2016 Oct; 99(4):802-816. PubMed ID: 27616483
[TBL] [Abstract][Full Text] [Related]
5. Functional assessment of triheteromeric NMDA receptors containing a human variant associated with epilepsy.
Marwick KFM; Hansen KB; Skehel PA; Hardingham GE; Wyllie DJA
J Physiol; 2019 Mar; 597(6):1691-1704. PubMed ID: 30604514
[TBL] [Abstract][Full Text] [Related]
6. A novel missense mutation in GRIN2A causes a nonepileptic neurodevelopmental disorder.
Fernández-Marmiesse A; Kusumoto H; Rekarte S; Roca I; Zhang J; Myers SJ; Traynelis SF; Couce ML; Gutierrez-Solana L; Yuan H
Mov Disord; 2018 Jul; 33(6):992-999. PubMed ID: 29644724
[TBL] [Abstract][Full Text] [Related]
7. Molecular Mechanism of Disease-Associated Mutations in the Pre-M1 Helix of NMDA Receptors and Potential Rescue Pharmacology.
Ogden KK; Chen W; Swanger SA; McDaniel MJ; Fan LZ; Hu C; Tankovic A; Kusumoto H; Kosobucki GJ; Schulien AJ; Su Z; Pecha J; Bhattacharya S; Petrovski S; Cohen AE; Aizenman E; Traynelis SF; Yuan H
PLoS Genet; 2017 Jan; 13(1):e1006536. PubMed ID: 28095420
[TBL] [Abstract][Full Text] [Related]
8. Functional Investigation of a GRIN2A Variant Associated with Rolandic Epilepsy.
Xu XX; Liu XR; Fan CY; Lai JX; Shi YW; Yang W; Su T; Xu JY; Luo JH; Liao WP
Neurosci Bull; 2018 Apr; 34(2):237-246. PubMed ID: 28936771
[TBL] [Abstract][Full Text] [Related]
9. Recurrent seizure-related GRIN1 variant: Molecular mechanism and targeted therapy.
Xu Y; Song R; Chen W; Strong K; Shrey D; Gedela S; Traynelis SF; Zhang G; Yuan H
Ann Clin Transl Neurol; 2021 Jul; 8(7):1480-1494. PubMed ID: 34227748
[TBL] [Abstract][Full Text] [Related]
10. Mutations in GRIN2A and GRIN2B encoding regulatory subunits of NMDA receptors cause variable neurodevelopmental phenotypes.
Endele S; Rosenberger G; Geider K; Popp B; Tamer C; Stefanova I; Milh M; Kortüm F; Fritsch A; Pientka FK; Hellenbroich Y; Kalscheuer VM; Kohlhase J; Moog U; Rappold G; Rauch A; Ropers HH; von Spiczak S; Tönnies H; Villeneuve N; Villard L; Zabel B; Zenker M; Laube B; Reis A; Wieczorek D; Van Maldergem L; Kutsche K
Nat Genet; 2010 Nov; 42(11):1021-6. PubMed ID: 20890276
[TBL] [Abstract][Full Text] [Related]
11. GRIN2A-related disorders: genotype and functional consequence predict phenotype.
Strehlow V; Heyne HO; Vlaskamp DRM; Marwick KFM; Rudolf G; de Bellescize J; Biskup S; Brilstra EH; Brouwer OF; Callenbach PMC; Hentschel J; Hirsch E; Kind PC; Mignot C; Platzer K; Rump P; Skehel PA; Wyllie DJA; Hardingham GE; van Ravenswaaij-Arts CMA; Lesca G; Lemke JR;
Brain; 2019 Jan; 142(1):80-92. PubMed ID: 30544257
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic Insight into NMDA Receptor Dysregulation by Rare Variants in the GluN2A and GluN2B Agonist Binding Domains.
Swanger SA; Chen W; Wells G; Burger PB; Tankovic A; Bhattacharya S; Strong KL; Hu C; Kusumoto H; Zhang J; Adams DR; Millichap JJ; Petrovski S; Traynelis SF; Yuan H
Am J Hum Genet; 2016 Dec; 99(6):1261-1280. PubMed ID: 27839871
[TBL] [Abstract][Full Text] [Related]
13. Modelling and treating GRIN2A developmental and epileptic encephalopathy in mice.
Amador A; Bostick CD; Olson H; Peters J; Camp CR; Krizay D; Chen W; Han W; Tang W; Kanber A; Kim S; Teoh J; Sah M; Petri S; Paek H; Kim A; Lutz CM; Yang M; Myers SJ; Bhattacharya S; Yuan H; Goldstein DB; Poduri A; Boland MJ; Traynelis SF; Frankel WN
Brain; 2020 Jul; 143(7):2039-2057. PubMed ID: 32577763
[TBL] [Abstract][Full Text] [Related]
14. De novo GRIN variants in NMDA receptor M2 channel pore-forming loop are associated with neurological diseases.
Li J; Zhang J; Tang W; Mizu RK; Kusumoto H; XiangWei W; Xu Y; Chen W; Amin JB; Hu C; Kannan V; Keller SR; Wilcox WR; Lemke JR; Myers SJ; Swanger SA; Wollmuth LP; Petrovski S; Traynelis SF; Yuan H
Hum Mutat; 2019 Dec; 40(12):2393-2413. PubMed ID: 31429998
[TBL] [Abstract][Full Text] [Related]
15. GRIN2D/GluN2D NMDA receptor: Unique features and its contribution to pediatric developmental and epileptic encephalopathy.
Camp CR; Yuan H
Eur J Paediatr Neurol; 2020 Jan; 24():89-99. PubMed ID: 31918992
[TBL] [Abstract][Full Text] [Related]
16. De novo GRIN variants in M3 helix associated with neurological disorders control channel gating of NMDA receptor.
Xu Y; Song R; Perszyk RE; Chen W; Kim S; Park KL; Allen JP; Nocilla KA; Zhang J; XiangWei W; Tankovic A; McDaniels ED; Sheikh R; Mizu RK; Karamchandani MM; Hu C; Kusumoto H; Pecha J; Cappuccio G; Gaitanis J; Sullivan J; Shashi V; Petrovski S; Jauss RT; Lee HK; Bozarth X; Lynch DR; Helbig I; Pierson TM; Boerkoel CF; Myers SJ; Lemke JR; Benke TA; Yuan H; Traynelis SF
Cell Mol Life Sci; 2024 Mar; 81(1):153. PubMed ID: 38538865
[TBL] [Abstract][Full Text] [Related]
17. De novo GRIN2A variants associated with epilepsy and autism and literature review.
Mangano GD; Riva A; Fontana A; Salpietro V; Mangano GR; Nobile G; Orsini A; Iacomino M; Battini R; Astrea G; Striano P; Nardello R
Epilepsy Behav; 2022 Apr; 129():108604. PubMed ID: 35217385
[TBL] [Abstract][Full Text] [Related]
18.
Pierson TM; Yuan H; Marsh ED; Fuentes-Fajardo K; Adams DR; Markello T; Golas G; Simeonov DR; Holloman C; Tankovic A; Karamchandani MM; Schreiber JM; Mullikin JC; ; Tifft CJ; Toro C; Boerkoel CF; Traynelis SF; Gahl WA
Ann Clin Transl Neurol; 2014 Mar; 1(3):190-198. PubMed ID: 24839611
[TBL] [Abstract][Full Text] [Related]
19. Sodium channel alpha1-subunit mutations in severe myoclonic epilepsy of infancy and infantile spasms.
Wallace RH; Hodgson BL; Grinton BE; Gardiner RM; Robinson R; Rodriguez-Casero V; Sadleir L; Morgan J; Harkin LA; Dibbens LM; Yamamoto T; Andermann E; Mulley JC; Berkovic SF; Scheffer IE
Neurology; 2003 Sep; 61(6):765-9. PubMed ID: 14504318
[TBL] [Abstract][Full Text] [Related]
20. The GluN2B-Glu413Gly NMDA receptor variant arising from a de novo GRIN2B mutation promotes ligand-unbinding and domain opening.
Wells G; Yuan H; McDaniel MJ; Kusumoto H; Snyder JP; Liotta DC; Traynelis SF
Proteins; 2018 Dec; 86(12):1265-1276. PubMed ID: 30168177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
